WO2011052946A2 - 재생성 세포 추출 시스템 - Google Patents
재생성 세포 추출 시스템 Download PDFInfo
- Publication number
- WO2011052946A2 WO2011052946A2 PCT/KR2010/007339 KR2010007339W WO2011052946A2 WO 2011052946 A2 WO2011052946 A2 WO 2011052946A2 KR 2010007339 W KR2010007339 W KR 2010007339W WO 2011052946 A2 WO2011052946 A2 WO 2011052946A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- unit
- chamber
- inlet
- cells
- extraction system
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
- C12M47/04—Cell isolation or sorting
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M45/00—Means for pre-treatment of biological substances
- C12M45/05—Means for pre-treatment of biological substances by centrifugation
Definitions
- the present invention relates to a regenerative cell extraction system, in particular by the automated program in the process of collecting the adipose tissue and separation of the regenerative cells from the adipose tissue, each step, pure adipose tissue, pure mature fat cells
- the present invention relates to a regenerative cell extraction system capable of selectively obtaining oil and fat-derived stem cells, respectively, and easily controlling the amount of regenerative cells harvested.
- Stem cells are defined as cells that possess clonogenic and self-renewing ability that can differentiate into multiple cell lines under certain conditions.
- Embryonic stem cells are derived from mammalian embryos at the blastocyst stage and possess the ability to differentiate into almost all cells present in the body, while adult stem cells are stem cells that are present in trace amounts in differentiated tissue after birth. It is a cell with the capacity of a cell.
- Adult stem cells offer practical advantages over embryonic stem cells. Unlike embryonic stem cells, adult stem cells can be extracted from the patient itself without causing ethical problems. They are abundant in supply and inherent in various tissues of the human body.
- the most available sources of adult stem cells are bone marrow, peripheral blood, umbilical cord / umbilical cord blood and adipose tissue, as confirmed in recent studies. These cells can maintain, yield and replace the final differentiated cells in their own specific tissues as a result of tissue damage due to physiological cell turnover or wounds.
- Adipose tissue has been found to be a source of stem cells, progenitor cells and matrix material suitable for therapeutic applications.
- Adipose tissue is also a rich source of vascular endothelial cells, which can play a role in tissue regeneration and tissue engineering by promoting growth of renal blood vessels and stimulating stem and progenitor cell growth.
- the technical problem to be achieved by the present invention is a fully automated process by a program in a closed state from the collection of adipose tissue to the treatment of tissue, improve the purity of regenerated cells collected from adipose tissue and finally put in a syringe It is to provide a regenerated cell extraction system that can be reduced to an amount that can be used immediately, and reduces the need for a separate operation after extraction of the cells.
- Regeneration cell extraction system for achieving the above technical problem is provided with a first unit, a second unit and a transfer unit.
- the first unit collects the tissues by vacuum suction, separates blood contaminants from the tissues collected by stirring and centrifugation, separates the cells from the tissues from which the blood contaminants are separated, and removes the cells suspended in the liquid. Discharge it.
- the second unit receives the cells suspended in the liquid from the first unit, separates the regenerated cells by centrifugation, and has a smaller capacity than the first unit.
- a transfer unit is connected between the first unit and the second unit, injects washing water into the first unit and the second unit, and transfers extracts from the first unit and the second unit to corresponding bags. And, the cells suspended in the liquid extracted from the first unit is introduced into the second unit or the tissue and cell contaminants are transported.
- the regenerated cell extraction system is capable of complete automation controlled by a program from the collection of the adipose tissue to the extraction of the regenerated cells, and the adipose tissue is moved and separated in a sealed state, In each phase of adipose tissue separation, adipose tissue, mature fat cells, oil (fat) and fat-derived stem cells can be selectively obtained, respectively. It is very convenient to get a lot of pure fat and fat-derived stem cells.
- by varying the structure of the lower plate inside the second chamber in various ways only the necessary components can be selectively separated from the blood, and in this case, the desired tissue can be continuously separated regardless of the capacity of the second chamber. There is an advantage.
- FIG. 1 is a conceptual diagram illustrating a regenerative cell extraction system according to an embodiment of the present invention.
- 2A is a cross-sectional view illustrating the structure of the first unit.
- FIG. 2B is a view showing another structure of the first unit of FIG.
- FIG 3 is a cross-sectional view illustrating the structure of the second unit.
- FIG. 4 is a plan view illustrating a structure of the lower plate part of FIG. 3.
- FIG. 5 is a plan view illustrating another structure of the lower plate part of FIG. 3.
- FIG. 6 (a) is a plan view of the selective discharge unit coupled to the lower plate of FIG.
- FIG. 6 (c) is a cross-sectional view of the second unit for explaining the structure in which the selective discharge portion is coupled to the lower plate portion.
- FIG. 7 is a plan view illustrating another structure of the lower plate part of FIG. 3.
- FIG. 8 is a cross-sectional view illustrating a state in which the lower plate part of FIG. 7 is mounted.
- FIG. 9 is a cross-sectional view illustrating a state in which the lower plate portion of another structure is mounted on the second chamber.
- Regeneration cell extraction system for achieving the above technical problem is provided with a first unit, a second unit and a transfer unit.
- the first unit collects the tissues by vacuum suction, separates blood contaminants from the tissues collected by stirring and centrifugation, separates the cells from the tissues from which the blood contaminants are separated, and removes the cells suspended in the liquid. Discharge it.
- the second unit receives the cells suspended in the liquid from the first unit, separates the regenerated cells by centrifugation, and has a smaller capacity than the first unit.
- a transfer unit is connected between the first unit and the second unit, injects washing water into the first unit and the second unit, and transfers extracts from the first unit and the second unit to corresponding bags. And, the cells suspended in the liquid extracted from the first unit is introduced into the second unit or the tissue and cell contaminants are transported.
- the tissue is adipose tissue, and the regenerative cells are adipose derived stem cells.
- the first unit is formed in a cylindrical upper body portion, the lower portion of the upper body portion integrally and inclined toward the center toward the lower portion, and integrally formed in the middle body portion and the upper body downward Through the first chamber and a guide hole formed in the center of the cover portion having a lower body portion which is smaller than the inner diameter of the portion and having the same inner diameter and a cover portion integrally formed on the upper surface of the upper body portion to cover the upper surface;
- a central tube inserted into the bottom surface of the lower body to a predetermined distance, wherein the tissue is introduced into the first chamber through an upper portion of the central tube, and the cells suspended in the liquid are discharged from the first chamber;
- At least one first wing is formed in the direction of the central tube to smoothly stir the tissue collected on the inner wall of the intermediate body of the first chamber.
- the first chamber is inserted into the guide hole surrounding the central tube, is formed integrally with the central tube, and a negative pressure tube is formed to make the first chamber in a negative pressure state, and the wall surface forming the guide hole and the A retainer is mounted between the negative pressure pipes so that the first chamber rotates independently of the central pipe and the negative pressure pipe while maintaining the airtightness.
- the lower end of the center tube is spaced apart from the bottom surface of the lower body portion is between 0.1mm ⁇ 3mm from the bottom surface.
- the central tube has at least one auxiliary wing protruding outward from a portion inserted into the first chamber.
- a bearing for smoothly rotating the first chamber may be further mounted between the wall surface forming the guide hole and the negative pressure pipe, and the bearing may be provided to facilitate the rotation of the first chamber.
- a filter for filtering foreign matter may be mounted inside the lower body portion of the lower portion of the central tube.
- the second unit has an inlet portion having a constant diameter and extending vertically downward, and a cylindrical upper portion whose inner diameter increases from the lower portion of the inlet portion to the lower portion thereof and decreases from the cell separation portion having the maximum inner diameter toward the lower portion thereof.
- the second chamber consisting of a body portion, the lower body portion integrally formed at the lower portion of the upper body portion and extending downward with a constant inner diameter, from the lower portion of the inlet portion to the inner diameter increases from the lower portion to the cell separation portion
- the upper plate portion When referred to as the upper plate portion, and installed to correspond to the inner surface of the upper plate portion, a passage through which the physiological buffers other than the regenerative cells existing in the second chamber is formed between the upper plate portion, and formed inside the inlet portion Cylindrical first inner inlet portion having a first inner diameter to be surrounded by the first inner inlet portion is larger than the first inner diameter
- a lower plate portion having a second inner inlet portion having a second inner diameter, and the second chamber through the first inner inlet portion for introducing a cell suspended in the liquid discharged from the first unit into the second chamber;
- An inlet tube inserted into the inside of the second chamber is inserted into the second chamber longer than the inlet tube, and discharges the regenerated cells formed on the bottom
- the second chamber rotates independently of the inlet tube, the first outlet tube and the second outlet tube by a retainer, and maintains hermeticity.
- the inlet pipe has a first support wing surrounding the outer wall surface of the first inner inlet portion on the outside, the second discharge pipe has a second support wing surrounding the inlet portion,
- the second chamber is independently rotated while retaining the retainer is mounted do.
- the input tube is inserted to the lower end of the upper body portion, and the first discharge tube is inserted to the height of 0.1mm ⁇ 2mm from the bottom surface of the lower body portion.
- At least one second wing portion for smoothly stirring the second chamber is formed on the inner wall surface from the cell separator to the lower end of the upper body portion in the direction of the input tube.
- the lower plate part is integrally formed at the lower end of the first inner inlet part and the second inner inlet part, and the first inner inlet part and the second inner inlet part, and has a same slope as the inclination of the upper plate part to have a hat shape.
- a circular plate extending and forming the passage together with the upper plate portion, wherein at least one passage between the upper plate portion and the lower plate portion is present, and the circular plate portion between the passage and the passage is bonded to the upper plate portion.
- the lower plate part is integrally formed at the lower end of the first inner inlet part and the second inner inlet part, and the first inner inlet part and the second inner inlet part, and has a same slope as the inclination of the upper plate part to have a hat shape.
- a circular flat plate that extends and forms the passage together with the upper plate portion, and surrounds the outer side of the second inner inlet portion of the lower plate portion, and selectively connects at least one passage among the passages to the second discharge pipe.
- a top discharge hole is formed, and a side discharge hole connected to the selected passage is formed at a side thereof, and a lower end of the side is coupled to a coupling groove formed at an upper surface of the circular plate, and the selective discharge portion is closely coupled to the coupling groove and then rotated. To select the passageway.
- a strainer that can filter out undigested tissue or collagen mass in the liquid cells introduced through the feed tube is further installed inside the lower body portion of the bottom of the feed tube.
- the lower plate part is integrally formed at the lower end of the first inner inlet part and the second inner inlet part, and the first inner inlet part and the second inner inlet part, and has a same slope as the inclination of the upper plate part to have a hat shape.
- a circular plate portion integrally formed at the end of the circular plate and the circular plate, the passage having a plurality of cylindrical wings formed therein, and surrounding the outer side of the second inner inlet portion of the lower plate portion, among the cylindrical wings.
- a hollow flat disk-shaped selective discharge portion for selecting at least one cylindrical wing and connecting a passage inside the selected cylindrical wing to the second discharge pipe, wherein the upper surfaces of the cylindrical wings are bonded to the upper plate portion, the lengths of which are mutually Differently, the component blood may be collected by dividing the blood component layer formed inside by the centrifugal force of the second chamber.
- the upper surface of the selective discharge portion has a through hole through which the second inner inlet portion penetrates and an upper surface discharge hole connected to the second discharge pipe to both sides of the through hole, and a side discharge side connected to the selected passage.
- the ball is formed, the lower end of the side is coupled to the coupling groove formed on the upper surface of the circular plate, the selective discharge portion is coupled to the coupling groove and then select the cylindrical wing by rotating.
- the lower plate part is integrally formed at the lower end of the first inner inlet part and the second inner inlet part, and the first inner inlet part and the second inner inlet part, and has a same slope as the inclination of the upper plate part to have a hat shape.
- One side end is coupled to the unfolding circular plate and the end of the circular plate and the inner wall surface of the second chamber and has a circular plate portion having a plurality of cylindrical wings are formed in the passage and the weight is mounted on the other end, the cylindrical
- the wings are made of an elastic material, the weights mounted on the respective cylindrical wings have different weights or the same weights to balance the cylindrical wings, depending on the centrifugal force due to the rotation of the second chamber
- the cylindrical wings are spread in the direction of the inner wall of the second chamber, and the component blood can be collected according to the blood component layer.
- the circular plate portion has two symmetric cylindrical wings, and the weight mounted on the cylindrical wings has the same weight.
- the transfer unit may include: a first multiway valve connected to the plurality of bags, the first multiway valve, a second multiway valve connected to the first unit and the second unit, and the first multiway valve; A pump is connected to the second multi-way valve.
- the transfer unit includes a plurality of solenoid valves connected to the plurality of bags, respectively, instead of the first and second multiway valves, and a transfer tube controlled by the solenoid valves is connected to the pump.
- the transfer unit is inserted with a transfer filter capable of filtering out foreign substances such as undigested enzyme mass or collagen mass contained in the liquid cells transferred from the first unit to the second unit.
- the transfer filter is a double filter.
- Each of the first unit and the second unit is provided with a jig to be rotated at a constant temperature, the jig is capable of adjusting the temperature and rotational speed of the mounted first unit and the second unit.
- FIG. 1 is a conceptual diagram illustrating a regenerative cell extraction system according to an embodiment of the present invention.
- the regenerated cell extraction system 10 includes a first unit 100, a second unit 200, and a transfer unit 700.
- the first unit 100 collects the tissue by vacuum suction, separates blood contaminants from the tissues collected by stirring and centrifugation, and separates cells from the tissues from which the blood contaminants are separated and suspended in a liquid. To drain the cells.
- the second unit 200 receives the cells suspended in the liquid from the first unit 100, separates the regenerated cells by centrifugation, and has a smaller capacity than the first unit 100.
- the first unit 100 has a larger capacity than the second unit 200.
- the second unit 200 alone can extract the necessary stem cells from the fat.
- the first unit 100 is required for the treatment of a large amount of fat that is difficult for the second unit 200 to process alone. For example, when processing about 1 liter of tissue, the tissue is concentrated in small amounts by the first unit 100 and then delivered to the second unit 200 to extract stem cells.
- the first unit 100 concentrates the cells in a large amount of fat cells and transmits them to the second unit 200.
- the transfer part 700 is connected between the first unit 100 and the second unit 200, injects the washing water into the first unit 100 and the second unit 200, and supplies the first unit 100 and the first unit 100.
- the extract from the second unit 200 is transferred to the corresponding bags B1 and B2-Bn, and the cells suspended in the liquid separated from the first unit 100 are introduced into the second unit 200. Or transport tissue and cell contaminants.
- the tissue is adipose tissue
- the regenerative cells are adipose derived stem cells.
- the regenerated cell extraction system 10 according to the embodiment of the present invention disclosed in FIG. 1 solves the above problems. That is, complete automation controlled by the program from the collection of adipose tissue to the extraction of regenerated cells is possible, and the adipose tissue is moved and separated in a sealed state, and in each stage of the separation of adipose tissue, the washed fat is completed. Tissue, pure mature fat cells, oil (derived fat cells) and adipose derived stem cells can be selectively obtained respectively.
- the regenerative cell extraction system 10 may perform the operations of extraction of fat-derived stem cells, recovery of pure adipose tissue from which blood-derived contaminants have been removed, and extraction of pure mature fat cells and oil (fat cell-derived).
- the unit 100 may have a larger capacity than the second unit 200, and the adipose tissue may be directly collected from the human body by vacuum suction. This can be done by directly connecting the liposuction unit to the first unit 100.
- the existing device is less risk of contamination and simple work process compared to once the tissue collected from the human body in a separate bag and then transferred to the regenerated cell extraction device.
- the transfer part 700 between the first unit 100 and the second unit 200 is connected to the first unit 100 and the second unit 200 by a pump and a valve, and the first unit 100 and the second unit 200 are connected to each other.
- necessary materials such as washing water and enzymes are introduced, and the cells suspended in the liquid from which blood contaminants are removed from the first unit 100 are extracted to separate bags B1 and B2-Bn.
- the liquid containing fat-derived stem cells, the fat-derived stem cells are separated from the second unit 200 to separate bags (B1, B2-Bn) Save it.
- a multiway valve may be used as the valve.
- the multi-way valve has a flat, round disc shape, and a plurality of passages are formed along the circumferential side of the disc, and a rotating body for selecting one of the plurality of passages is formed at the center.
- the passages may be connected to the corresponding plurality of bags B1 and B2-Bn, respectively, and the material is moved and stored in the bag connected to the selected passage through the rotating body.
- the upper surface of the rotating body is formed with a connection hole connected to the rotating body of another multi-way valve.
- the transfer part 700 may include a first multiway valve (not shown) connected to the plurality of bags B1 and B2-Bn, and a second multiway valve connected to the first unit 100 and the second unit 200. (Not shown), and a pump (not shown) connecting the first multi-way valve and the second multi-way valve.
- the second multi-way valve is connected to the central tube 160 of the first unit 100 and the input tube 270 of the second unit 200.
- the first multiway valve may use a passage having as many as the bags B1 and B2-Bn, and the number of passages of the second multiway valve may be equal to or less than the number of passages of the first multiway valve. have.
- the pump is disposed between the first multiway valve and the second multiway valve to allow material to move between the first multiway valve and the second multiway valve. As a pump a peristertic pump can be used.
- the transfer unit 700 includes a plurality of transfer pipes (not shown) and solenoid valves (not shown) connected to the plurality of bags B1 and B2-Bn, respectively, instead of the first and second multi-way valves.
- Solenoid valves may be configured to control the delivery pipe connected to the pump (not shown). That is, the plurality of bags B1 and B2-Bn may be connected to the first unit 100 or the second unit 200 through the transfer tube, and the first unit 100 may be opened and closed by the solenoid valve. The substance discharged from) can be stored in the connected bags B1, B2-Bn.
- 2A is a cross-sectional view illustrating the structure of the first unit.
- the first unit 100 includes a first chamber 110 and a central tube 160.
- the first chamber 110 is a part that rotates to remove blood contaminants and separate cells by receiving tissue, and has a lower tapered cylinder.
- the first chamber 110 is decomposed using aspiration of adipose tissue, removal of blood-derived contaminants, dehydration (separation) of pure adipose tissue, and enzymes (usually using collagenase but other enzymes may be used alone or in combination). The operation is performed.
- the first chamber 110 is formed in the lower body of the cylindrical upper body portion 120, the upper body portion 120 and the intermediate body portion 130 which is inclined toward the center toward the lower portion and
- the lower body portion 140 is integrally formed on the middle body portion 130 and extends downwardly with the same inner diameter while smaller than the inner diameter of the upper body portion 120, and integrally formed on the upper surface of the upper body portion 120. It is formed with a cover portion 150 to cover the upper surface.
- the shape of the bottom surface of the lower body portion 140 may vary, but preferably has a structure in which the bottom surface slightly protrudes in a U shape as shown in FIG. 2.
- the size of the first chamber 110 is about 120mm in diameter, about 170mm in height, larger than the second chamber 210 of the second unit 200, and the size is adjusted according to the capacity of the adipose tissue to be treated. Can be.
- the height of the first chamber 110 may be about 50mm, about 1,000-2,000cc, about 150mm, and about 2,000-3,000cc, about 250mm.
- the central tube 160 is inserted to a position spaced a predetermined distance from the bottom surface of the lower body portion 140 through the guide hole 151 formed in the center of the cover portion 150.
- the position where the lower end of the central tube 160 is spaced apart from the bottom surface of the lower body portion 140 is between 0.1mm ⁇ 3mm from the bottom surface.
- the tissue is introduced into the first chamber 110 through the upper portion of the central tube 160, and the cells are discharged from the first chamber 110.
- the stopper is of the same structure as seen in the safety syringe (luer lok structure) is connected directly to the liposuction vacuum is applied to the negative pressure tube 190 to be described later
- the fat sucked by the negative pressure can directly enter the first chamber 110, and is sealed until it is mounted on the fat cell separator after the suction of fat.
- Adipose tissue may be transferred to the first chamber 100 by the negative pressure induced by the liposuction device, or may be transferred into the first chamber 100 using a pump embedded in the regenerative cell extraction apparatus of the present invention. .
- the first chamber 110 surrounds the central tube 160 and is inserted into the guide hole 151, is formed integrally with the central tube 160, and has a negative pressure tube 190 for making the first chamber 110 in a vacuum sound pressure state. Is formed, and the first chamber 110 rotates independently of the central tube 160 and the negative pressure tube 190 between the wall surface 153 and the negative pressure tube 190 forming the guide hole 151 to maintain hermeticity.
- a retainer 180 is mounted.
- the retainer is an element that functions to assist the rotation, such as a bearing, and to seal the air from passing through, and it is natural that an element for performing such a function can be used in addition to the retainer.
- a bearing (not shown) for smoothly rotating the first chamber 110 may be further installed between the wall surface 153 and the sound pressure pipe 190 forming the guide hole 151, together with a retainer. have.
- a filter (not shown) capable of smoothing the treatment of fat cells by filtering foreign substances present in the tissue introduced through the central tube, that is, other than fatty tissue, for example, collagen, may be provided. 160 may be mounted inside the lower body 140 of the lower portion.
- the negative pressure unit 190 is equipped with a filter 191 for preventing the back flow of contaminated air.
- Negative pressure unit 190 is a negative pressure for adipose tissue collection in the operating room, that is, the portion that can be connected to the vacuum inhaler, so the stopper and the stopper portion of the negative pressure unit 190 is preferably formed in the form of a safety syringe Do.
- the type of filter 191 may vary, and may be a 0.22 um air filter to prevent backflow of contaminated air in a vacuum inhaler.
- At least one first wing 170 is formed in the direction of the central tube 160 on the inner wall of the intermediate body 130 of the first chamber 110 to smoothly stir the collected tissue.
- four first wings 170 are mounted at a 90-degree angle inside the first chamber 110 with a thickness of about 1-2 mm.
- the first wing unit 170 allows the adipose tissue and the washing water to mix well when the first chamber 110 repeats rotation and stop.
- the central tube 160 may include at least one auxiliary wing 175 protruding outward from a portion inserted into the first chamber 110.
- the auxiliary wing 175 also allows the first chamber 110 to mix well with the adipose tissue and the wash water when the rotation and stop are repeated.
- the first unit 100 is mounted on a jig (not shown) to rotate while maintaining a constant speed and temperature.
- the jig can adjust the temperature and the rotational speed of the first unit 100, and its structure and operation can be understood by those skilled in the art, so a detailed description thereof will be omitted.
- the jig in which the first unit 100 is mounted may allow the first unit 100 to perform only a function of stirring using vibration, not rotation, using an eccentric motor.
- the operation of the first unit 100 will be described below.
- fat tissue is absorbed from the human body.
- Open the lid of the upper portion of the negative pressure unit 190 also connects the vacuum inhaler. Then, a vacuum inhaler is operated to collect fat tissue directly from the body. The collected adipose tissue contains blood and the like.
- the regenerative cell extraction system 10 of the present invention is a liposuction apparatus and a vacuum inhaler.
- the negative pressure pipe 190 connected to the vacuum inhaler has a filter 191 so that bacterial contamination by external air may not occur even if the cap is opened.
- the fat-derived stem cell kit (kit) of the transfer unit 700 is connected to an upper portion of the central tube 160 to which the adipose tissue collecting needle is connected.
- this kit has several bags (B1, B2 ⁇ Bn) connected to each bag, and each bag is equipped with a solenoid valve, which normally blocks the transfer tube connected to the solenoid valve.
- Enzyme (collagenase), the bag for storing the adipose tissue from which blood is removed, the bag to collect the liquid discarded after processing, the bag connected to the second unit 200 is attached, and can be configured in various ways depending on the application .
- a kit configured using a multiway valve and a pump may be connected to the transfer unit 700.
- the solenoid valve in front of the bags is necessary. no.
- the first unit 100 is mounted on a jig capable of rotation and temperature control having an inner diameter equal to the outer diameter of the first unit 100.
- a jig capable of rotation and temperature control having an inner diameter equal to the outer diameter of the first unit 100.
- the operation to absorb the fat tissue while mounting from the beginning may be performed.
- the first unit 100 and the second unit 200 may be mounted to the jig to rotate while maintaining a constant temperature.
- the jig (not shown) is capable of adjusting the temperature and rotational speed of the first unit 100 and the second unit 200 mounted.
- the first unit 100 is left as it is for about 1 minute to separate the fat tissue and water from the absorbed fat tissue. Then, the adipose tissue is positioned above the water in the first chamber 110. After connecting the pump of the transfer unit 700 to the tube of the kit, the pump is operated to remove the water contaminated with the blood submerged in the lower portion of the first chamber 110 through the central tube 160 to remove. At this time, the sensor is mounted on the connection pipe between the pump and the bag containing the water contaminated with blood and automatically stops the pump when all the water including blood passes. Unlike the adipose tissue, the color of the water containing the blood is reddish due to the blood or is very dark compared to the adipose tissue. Therefore, the sensor senses the color (or brightness or density or permeability) of the substance passing through the tube. It is possible to control the operation of the pump by distinguishing between and other substances.
- the operation of the pump may be controlled by sensing the difference in specific gravity. Since the operation of such a sensor can be understood by those skilled in the art, a detailed description thereof will be omitted.
- the washing water (saline) bag is opened and a similar amount of washing water is added to the remaining fat tissue in the first chamber 110 of the first unit 100 by the operation of the pump.
- a similar amount of washing water is added to the remaining fat tissue in the first chamber 110 of the first unit 100 by the operation of the pump.
- the amount of adipose tissue collected it is possible to set the amount of washing water introduced by the program in advance.
- the first chamber 110 is rotated.
- the speed or number of revolutions can also be set in advance by the amount of adipose tissue collected. For example, it can be adjusted by repeating 10 seconds, 10 seconds stop 5 times, etc. within about 300 revolutions per minute.
- the saline solution is added to wash the adipose tissue, and the washed water portion is removed again, and the saline solution is added again to repeat the operation 3-5 times. Finally remove the saline solution. Only as much fat tissue as necessary to separate adipose derived stem cells is left in the first chamber 110 and the remaining washed fat tissue is transferred to a bag for storing pure fat using a pump. That is, the regenerative cell extraction system 10 according to the embodiment of the present invention may separate only the pure adipose tissue remaining after washing as needed.
- the cells are separated using enzymes.
- a similar amount of enzyme (0.1% collagenase is used as the remaining fat cells remaining in the first chamber 110. However, one skilled in the art will understand that other enzymes may be used and the concentration may vary.)
- the pump is introduced into the first chamber 110 through the central tube 160. Also in this case, since the amount is estimated in advance, the amount of enzyme can be initially set in the program.
- the rotation and stop of the first chamber 110 are repeated according to the program. At this time, by applying heat to the outside of the first chamber 110 to maintain a temperature of about 37 degrees. This is done by the heat transferred from the jig to activate the enzyme.
- the rotation and stop are repeated for a certain time (for example, about 30 minutes), mature fat cells and fat-derived cells are decomposed by enzymes in the first chamber 110, and the rotation is stopped for about 3-5 minutes. Stopping separates the sap layer (lower layer), which contains mature fat cells (upper layer) and fat-derived cells. Then, the fluid layer containing the adipose derived cells separated from the collagenase treatment is moved to the second chamber 210 of the second unit 200 using a pump. If the mature fat cells and the liquid fats (oils) generated when the mature fat cells are collected or processed are needed, the enzyme (collagenase) is added to the first chamber 110 using the washing method. After washing with water five times, transfer to a mature fat cell storage bag using a pump. This process is also initially possible by program settings and can be controlled by the sensor.
- a certain time for example, about 30 minutes
- the first unit 100 may be directly harvested adipose tissue, extraction of pure adipose tissue, extraction of mature fat cells using enzymes and separation of cells to separate stem cells, this operation is Conditions are set in advance by the program so that the whole or only necessary processes can be carried out separately.
- FIG. 2B is a view showing another structure of the first unit of FIG.
- the negative pressure unit 190 may be directly mounted in a state coupled to the cover unit 150.
- the negative pressure unit 190 may be equipped with a filter 191 for preventing the back flow of contaminated air.
- FIG 3 is a cross-sectional view illustrating the structure of the second unit.
- FIG. 4 is a plan view illustrating a structure of the lower plate part of FIG. 3.
- the second unit 200 includes a second chamber 210, a lower plate portion 264, an input pipe 270, a first discharge pipe 275, and a second discharge pipe 280. do.
- the second chamber 210 has a constant diameter and extends vertically downward in the inlet portion 220, and the inner diameter increases from the lower portion of the inlet portion 220 toward the lower portion of the cell separator 225 having the maximum inner diameter again.
- the upper body portion 230 has a cylindrical shape, the inner diameter of which decreases toward the lower portion, and is formed integrally with the lower portion of the upper body portion 230 and has a lower inner portion 240 extending downward with a constant inner diameter.
- the bottom surface of the lower body portion 240 may be flat or have a structure in which the bottom surface protrudes in a U shape as shown in FIG. 3.
- the second chamber 210 is formed to be inclined toward the center from the cell separation unit 225 of the upper body portion 230 toward the bottom, which is the outer side of the second chamber 210 when the second chamber 210 is rotated (wall side).
- the centrifugal force acts largely), so that the fat-derived stem cells separated during the inflow and separation of the liquid containing the fat-derived stem cells can be gathered to the cell separation unit 225.
- the liquid solution in which the fat-derived stem cells have been removed is to prevent the cells from easily coming out together when removed to the upper outlet.
- the lower plate portion 264 is installed so as to correspond to the inner surface of the upper plate portion 250 when the cell separation portion 225 is referred to as the upper plate portion 250 in a portion where the inner diameter increases from the lower portion of the lower portion of the inlet portion 220 to the lower portion.
- physiological buffers other than the regenerative cells existing inside the second chamber 210 are discharged along the passage 265 between the upper plate 250 and the lower plate 264.
- the lower plate portion 264 is integrally connected with the upper end of the lower plate portion 264, and surrounds the cylindrical first inner inlet portion 261 and the first inner inlet portion 261 having the first inner diameter and are smaller than the first inner diameter.
- the second inner inlet part 263 having a large second inner diameter extends inside the inlet part 220.
- the input tube 270 is inserted into the second chamber 210 through the first internal inlet part 261 in order to introduce the cells discharged from the first unit 100 into the second chamber 210.
- the first discharge pipe 275 penetrates the inside of the input pipe 270 and is inserted into the second chamber 210 longer than the input pipe 270 and the bottom of the lower body part 240 of the second chamber 210. It becomes a passage for discharging the regenerated cells formed on the cotton.
- the input pipe 270 is inserted to the lower end of the upper body portion 230, the first discharge pipe 275 is inserted to the height of 0.1 ⁇ 2mm from the bottom surface of the lower body portion 240.
- the upper portion of the first discharge pipe 275 has a shape in which a safety syringe can be mounted to discharge the recovered fat-derived stem cells to the outside, and is plugged with a stopper or connected to a kit for performing this process. Since the end of the first discharge pipe (275) is lowered to a height of 0.1 ⁇ 2mm from the bottom surface of the lower body portion 240, the fat-derived stem cells accumulated on the bottom surface of the lower body portion 240 is the first discharge pipe (275) It is discharged through the outside.
- An injection tube 270 is used to surround the first discharge tube 275 and to transfer cells from the first unit 100 to the second unit 200.
- the second discharge pipe 280 is inserted between the outer wall surface of the second inner inlet 263 and the inner wall surface of the inlet 220 to be discharged through the passage 265 between the upper plate 250 and the lower plate 264.
- the physiological buffer other than the regenerated cells is discharged to the outside.
- the second chamber 210 rotates independently of the input pipe 270, the first discharge pipe 275, and the second discharge pipe 280 by retainers 281 and 283, and maintains hermeticity.
- the process of washing the fat-derived stem cells contained in the sap containing the enzyme transferred from the first unit 100 and separating the fat-derived stem cells is performed.
- Inlet pipe 270 has a first support wing 271 surrounding the outer wall surface of the first inner inlet portion 261 on the outside, the second discharge pipe 280 is a second surrounding the inlet portion 220 A support wing 285 is provided.
- the second chamber 210 rotates independently of the input pipe 270, the first discharge pipe 275, and the second discharge pipe 280. 281, 283 serves to assist the sealing to be possible.
- the second chamber 210 is formed. It is equipped with a retainer to rotate independently and maintain hermeticity.
- the retainer is an element that functions to assist rotation, such as a bearing, and keeps air tight, and it is obvious that elements other than the retainer can perform the same function.
- Bearings for smoothing the rotation of the two chambers 210 may be mounted at the same time.
- the second chamber 210 may stir the internal material when the second chamber 210 rotates on the inner wall surface from the cell separator 225 to the lower end of the upper body 230.
- At least one smoothing of the second wing 211 is formed in the direction of the input pipe 270.
- four second wings 211 may be arranged at intervals of 90 degrees, the outer of the inlet pipe 270 as in 175 of the first chamber 110
- the second wing portion (not shown) may be mounted on the.
- the lower plate portion 264 includes a first inner inlet portion 261, a second inner inlet portion 263, and a circular plate 260.
- the circular plate 260 is integrally formed at the lower ends of the first inner inlet part 261 and the second inner inlet part 263 to be unfolded in the shape of a hat with the same inclination as that of the upper plate part 250 and the upper plate part 250. Together form a passage 265.
- At least one passage 265 between the upper plate 250 and the lower plate 264 is present, and the portion 410 of the circular plate 260 between the passage and the passage is bonded to the upper plate 250.
- the predetermined portion 410 of the circular plate 260 of the lower plate portion 264 is bonded to the upper plate portion 250.
- the portion 410 and the portion 410 adhered to the upper plate 250 are separated from the upper plate 250 to naturally form a passage 265.
- the passage 265 is marked for easy understanding.
- the passage 265 is connected to the cell separator 225, which is the outermost part of the second chamber 210 by the centrifugal force and the cells inside the second chamber 210 by the centrifugal force.
- the second discharge pipe 280 Applying a negative pressure or positive pressure in the second chamber 210, or both at the same time by extracting the washing water through the passage 265, only a few liquid and stem cells remain inside the second chamber (210) To be.
- a sieve 213 that can filter out the rest of undecomposed tissue including collagen mass or collagen mass from the liquid cells introduced through the input tube 270 has a lower body portion 240 under the input tube 270. It can be installed inside.
- the filter net 213 is a mesh net having a gap of about 0.5-2 mm, which is completely digested when cells are introduced from the first unit 100 to the second unit 200 through the input tube 270. Collagen mass or part of the tissues (various substances not decomposed by the enzymes used in the first unit 100) are filtered out from the strainer 213.
- the regeneration cell collected in the cell separation unit 225 may be provided with a barrier 215 at the inlet of the passage 265 so that only the washing water may escape without passing through the passage 265.
- the barrier layer 215 may be disposed in a portion of the passage 265 between the circular plate 260 and the inner wall surface of the upper plate 250 unlike the structure of the lower plate 264.
- the barrier layer 215 may have a hole in the center as shown in FIG. 4, and a portion of the barrier layer 215 may be bonded to the inner wall surface of the upper plate part 250 as shown in part 410 of FIG. 4.
- Saline containing collagenase and cells from the first unit 100 is slowly filled in the second chamber 210 of the second unit 200 through the inlet tube 270.
- the second chamber 210 is initially stopped, and then rotates the second chamber 210 when a predetermined amount is filled in the second chamber 210.
- a predetermined amount For example, when the fat cells mixed with collagenase fill half of the total volume of the second chamber 210, the second chamber 210 is rotated to about 150G.
- the G value may be changed to 75G to 1,000G or more, and as the G value increases, the concentration time is shortened.
- the start time of rotation of the second chamber 210 is constant in the amount of liquid transferred per rotation of the pump. Therefore, the amount transferred by time calculation can be calculated, and these conditions can be programmed to start the rotation automatically.
- the second chamber 210 is also mounted on a jig (not shown) to rotate while maintaining a constant speed and temperature.
- the rotation time, the temperature, the rotational speed, etc. are set in advance by a program, and the first section 100 and the second unit 200 are controlled to automate the entire exaggeration from the collection of the adipose tissue to the separation of the adipose derived stem cells. can do.
- the physiological buffer containing cells from the first unit 100 is blocked for about 5 minutes to prevent loss of cells.
- the inflow of the physiological buffer containing the cells transmitted from the first unit 100 and the regeneration of the regenerated cells due to the rotation of the second chamber 210 proceed simultaneously with the outflow of the separated physiological buffer.
- the regenerative cells contained in the physiological buffer may be immediately leaked before they can be separated, thereby greatly reducing the recovery rate of the regenerative cells. Therefore, after filling the second chamber 210 to a predetermined amount or more, the cells are completely rotated for about 5 minutes to completely separate the regenerated cells from the physiological buffer and then gradually inflow and outflow of the physiological buffer containing the cells from the first unit 100. Resume should be to prevent the loss of regenerated cells.
- the physiological buffer containing the collagenase and the cell components remaining in the first unit 100 is continuously transferred to the second chamber 210, and at the same time, the liquid component is continuously maintained through the second discharge pipe 280. Washing water) is removed from the second chamber 210.
- the rotation removes the liquid component inside the second chamber 210, the adipose derived stem cells are collected in the cell separation unit 225 of the second chamber 210, and if the liquid component is continuously drawn out, slightly by centrifugal force Only the liquid remains in the second chamber 210. Even at this time of influx of physiological buffer and separation of fat-derived stem cells, coordination of rotational speed and inflow and outflow rates is very important to prevent the loss of regenerative cells.
- the second chamber 210 is introduced from the first chamber 110 through the inlet tube 270 mixed with the enzyme and the saline solution, and the liquid component except the stem cells through the passage 265 by rotation.
- the second discharge pipe 280 can be separated purely stem cells.
- the rotation of the second chamber 210 is stopped and the saline solution is added to the second chamber 210 again. Then, the rotation and stop operation of the second chamber 210 is repeated. For example, about 10 seconds of rotation, repeating 10 seconds stop 3-5 times. Thereafter, the saline solution is removed while rotating the second chamber 210 again. Repeat this washing process 3-5 times. After the last flushing process, the rotation of the second chamber 210 is stopped. When the rotation of the second chamber 210 is stopped, fat-derived stem cells gathered on the wall surface of the cell separation unit 225 ride on the inclined surface of the upper body part 230 to the bottom surface of the lower body part 240. It comes down.
- the stopper at the top of the first discharge tube 275 is removed and a syringe is inserted to extract saline solution containing a desired amount or whole amount of adipose derived stem cells into the syringe. Since the end of the first discharge pipe 275 comes down to the bottom surface 0.1-2mm of the lower body portion 240, the fat-derived stem cells collected on the bottom surface of the lower body portion 240 can be easily extracted to the outside.
- FIG. 5 is a plan view illustrating another structure of the lower plate part of FIG. 3.
- FIG. 6 (a) is a plan view of the selective discharge unit coupled to the lower plate of FIG.
- FIG. 6 (c) is a cross-sectional view of the second unit for explaining the structure in which the selective discharge portion is coupled to the lower plate portion.
- the lower plate part 264-1 may include a first internal inlet part 261, a second internal inlet part 263, and a first internal inlet part ( 261 and a circular plate 260 which is integrally formed at the lower end of the second inner inlet 263 and is unfolded in the shape of a hat with the same slope as that of the upper plate 250, and forms a passage 265 together with the upper plate 250.
- the structure includes at least one passage 265-1 between the upper plate 250 and the lower plate 264-1, and the circular plate portion 510 between the passage and the passage includes the upper plate 250. Is bonded to.
- the weights of the separated half portions are equal to each other, the lengths of the passages formed in one half portion are different from each other, and are formed in the separated half portions.
- the passages facing each other have the same length.
- the circular plate 260-1 has a structure in which passages 265-1 having different lengths from short to long are symmetrical to each other.
- desired materials can be obtained at required positions when different materials are to be obtained in each layer generated as a result of centrifugation such as blood by the rotation of the second chamber 210. have.
- the reason for having a symmetric structure is that vibration may occur in the rotating second chamber 210 if the center of gravity does not fit during centrifugation.
- the vibration does not occur even when the second chamber 210 is rotated.
- Adjusting the weight is a basic principle of the centrifugal separator, which will be understood by those skilled in the art, and thus detailed description thereof will be omitted.
- the upper surface 640 of the selective discharge part 600 includes a through hole 605 and a through hole 605 through which the second inner inlet part 263 penetrates in the center.
- An upper surface discharge hole 610 connected to the second discharge pipe 280 is formed.
- a portion of the inner wall surface 263-1 of the selective discharge part 600 forming the through hole 605 is upward and downward to easily contact the second internal inlet part 263, as shown in FIG. 6B. It extends by a certain length.
- a side discharge hole 615 is formed at the side of the selective discharge part 600 and is connected to the selected passage 265-1, and the lower end 620 of the side is formed at the upper surface of the circular plate 260-1. ) Is combined.
- the lower end portion 620 of the selective discharge unit 600 is inserted into the coupling groove 520 of the circular plate 260-1 is closely coupled.
- the side discharge hole 615 of the selective discharge part 600 rotates to select the corresponding passage 265-1.
- the lower side 620 of the selective discharge unit 600 and the coupling groove 520 is in close contact with each other can be sealed using a silicon ring, etc.
- the lower side 620 of the selective discharge unit 600 is a coupling groove
- the passage may be selected by rotating in engagement with 520.
- the structure in which the selective discharge unit 600 is coupled to the coupling groove 520 and rotates will be understood by those skilled in the art, and thus detailed description thereof will be omitted.
- the first unit 100 and the second unit 200 having such a structure are mounted on a rotating jig (not shown) to rotate, and the rotational speed may be set by a program in advance and automatically adjusted.
- the process of rotation or the extraction of adipose tissue and the separation of fat-derived stem cells and storage of the material into bags (B1 to Bn) can be automated by programs and software, which can be understood by those skilled in the software field. Detailed descriptions are omitted here.
- FIG. 7 is a plan view illustrating another structure of the lower plate part of FIG. 3.
- FIG. 8 is a cross-sectional view illustrating a state in which the lower plate part of FIG. 7 is mounted.
- FIG. 7 is a plan view and a side view of the lower plate portion 264-2 and the selective discharge unit 700 coupled to the lower plate portion 264-2.
- another structure of the lower plate part 264-2 according to the embodiment of the present invention constitutes a passage unlike the structures of the lower plate parts 264 and 264-1 of FIGS. 4 and 5.
- Cylindrical wing 750 is provided separately.
- the lower plate portion 264-2 includes a first inner inlet portion 261 and a second inner inlet portion 263, a circular plate portion 761, and a selective discharge unit 700.
- the circular plate portion 761 is integrally formed at the lower ends of the first inner inlet portion 261 and the second inner inlet portion 263, and has a circular plate 760 having the same slope as that of the upper plate portion 250. And a plurality of cylindrical wings 750 integrally formed at the end of the circular plate 760 and having a passage 265-2 formed therein.
- the selective discharge part 700 surrounds the outside of the second inner inlet part 263 of the lower plate part 264-2, selects at least one or more cylindrical blades from the cylindrical blades 750, and selects a passage inside the selected cylindrical wing ( 265-2) to have a hollow flat disk shape that connects the second discharge pipe 280.
- the upper surfaces of the cylindrical wings 750 are adhered to the upper plate 250 and their lengths are different from each other, thereby distinguishing the blood component layers formed therein by the centrifugal force of the second chamber 210. Component blood can be collected.
- the substances included in the physiological buffer containing fat-derived cells inside by centrifugal force form layers according to their specific gravity. Therefore, substances in the blood component layer may be separated and discharged along the length of the cylindrical wings 750.
- a through hole 705 through which the second inner inlet 263 penetrates in the center and an upper discharge hole 710 connected to the second discharge pipe 280 to both sides of the through hole 705. Is formed. (See the middle figure in Figure 7)
- a side discharge hole 715 is formed at a side of the selective discharge part 700 and is connected to the selected passage, and a lower end 720 of the side is coupled to the coupling groove 722 formed at the upper surface of the circular plate 760.
- the part 700 selects the cylindrical blade 750 by rotating after being closely coupled to the coupling groove 722.
- the selective discharge part 700 has a flat disc shape having a through hole 705.
- the lower end portion 720 is inserted into the coupling groove 722 of the circular plate 760, and the coupling groove 722 is provided. By rotating in side) the side discharge hole 715 can select the passage.
- the coupling groove 722 is provided with a device such as a silicon ring so that the coupling of the lower portion 720 and the coupling groove 722 can be sealed.
- the cylindrical blade 750 of the lower plate portion 264-2 is bonded to the corresponding upper plate portion 250.
- the circular plate 760 of the lower plate portion 264-2 has a coupling groove 722 formed along the circumference of the circular plate 760 on which the cylindrical blades 750 are formed, and the selective discharge portion in the coupling groove 722. 700) are combined.
- the inner wall surface 263-2 of the selective discharge part 700 forming the through hole 705 has a predetermined length in the upper and lower portions so as to be easily contacted with the second inner inlet part 263. Is formed extending.
- FIG. 9 is a cross-sectional view illustrating a state in which the lower plate portion of another structure is mounted on the second chamber.
- the lower plate portion includes a first inner inlet portion 261, a second inner inlet portion 263, and a circular plate portion 961.
- the circular plate portion 961 is integrally formed at the lower ends of the first internal inlet portion 261 and the second internal inlet portion 263, and has a circular plate 960 extending in the shape of a hat with the same slope as that of the upper plate portion 250. And one end is coupled to the end of the circular plate 960 and the inner wall surface of the second chamber 210, the passage (265-3) is formed on the inside and has a different weight to balance the cylindrical blade on the other end or It is provided with a plurality of cylindrical wings 950 is mounted with a weight (not shown) having the same weight.
- the lower plate portion 264-3 of FIG. 9 has cylindrical wings 950 formed at the end of the circular plate 960 similarly to the lower plate portion 264-2 of FIG. 7, but the lower plate portion 264-2 of FIG.
- the cylindrical blades 750 are attached to the upper plate 250 and are formed of a plurality of different lengths, in another embodiment, only two cylindrical wings 950 of FIG. 9 may be present.
- the cylindrical wings 950 are made of an elastic material, and weights (not shown) mounted on each cylindrical wing may have different weights or the same weight to balance the cylindrical wings with each other. .
- the weights mounted on the cylindrical wings should have the same weight.
- the cylindrical wings 950 are stretched downward by a weight (not shown) as shown in FIG. 9 when the second chamber 210 is stopped, and then occurs when the second chamber 210 rotates. According to the centrifugal force, the cylindrical wings 950 are unfolded in the direction of the inner wall surface of the second chamber 210, and the component blood can be collected according to the blood component layer.
- the cylindrical wings 950 are unfolded in the direction of the inner wall surface of the second chamber 210 according to the rotational speed of the second chamber 210. If the rotation speed is fast, the inner wall surface of the second chamber 210 is very close, and if the rotation speed is slow, the second chamber 210 will be far from the inner wall surface. In this manner, the cylindrical wings 950 may selectively discharge the material of the required layer from the blood component layer formed inside the second chamber 210.
- Cylindrical wing 950 is connected to the end of the circular plate 960, and should also be fixed to the inner wall surface of the second chamber (210). Looking at the circled portion of Figure 9, the opposite side of the circular plate 960 connecting portion of the cylindrical blade 950 is connected to the inner wall surface of the second chamber 210, to ensure fixing, one side of the cylindrical blade 950 The end portion may have a structure that is fixed to the locking step 970 formed on the inner wall surface.
- the cylindrical wing 950 may be fixed to the inner wall surface of the second chamber 210 may be various, and will be understood by those skilled in the art and will not be described in detail.
- the transfer unit 700 may include a transfer filter (not shown) capable of filtering out foreign substances such as undigested collagen mass contained in the liquid cells transferred from the first unit 100 to the second unit 200.
- the feed filter may be a double filter.
- the double filter has a structure in which the size of the holes formed in the mesh network is small and the outside is surrounded by the size of the holes formed in the mesh network.
- the double filter may have a structure in which a 0.5 mm to 2 mm filter and a 0.1 mm to 0.5 mm filter are sequentially mounted to the transfer part 700.
- the transfer filter may be a single filter rather than a double filter.
- various cells including stem cells may be separated from various tissues other than adipose derived stem cells.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Cell Biology (AREA)
- External Artificial Organs (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims (24)
- 진공흡입에 의하여 조직을 채취하고, 교반 및 원심분리에 의해 채취된 상기 조직으로부터 혈액오염물을 분리시키고, 상기 혈액오염물이 분리된 조직으로부터 세포를 분리하여 액체에 부유된 상태의 세포를 배출시키는 제1유닛 ;상기 제1유닛으로부터 상기 액체에 부유된 상태의 세포를 투입받고, 원심분리에 의해서 재생성세포를 분리하며 상기 제1유닛보다 소용량인 제2유닛 ; 및상기 제1유닛과 상기 제2유닛 사이에 연결되며, 상기 제1유닛과 상기 제2유닛에 세정수를 주입하고, 상기 제1유닛 및 상기 제2유닛으로부터의 추출물을 대응되는 백들로 전달하며, 상기 제1유닛에서 추출된 액체에 부유된 상태의 세포를 상기 제2유닛으로 투입시키거나 조직 및 세포오염물을 이송하는 이송부를 구비하는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 1 항에 있어서, 상기 조직은 지방조직이며, 상기 재생성세포는 지방유래줄기세포인 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 1항에 있어서, 상기 제1유닛은,원통형상의 상부몸통부와, 상기 상부몸통부의 하부에 일체로 형성되며 하방으로 갈수록 중심을 향해 경사지는 중간몸통부와, 상기 중간몸통부에 일체로 형성되며 하방으로 상기 상부몸통부의 내경보다 작으면서 동일한 내경을 가지고 연장되는 하부몸통부와, 상기 상부몸통부의 상부면에 일체로 형성되어 상부면을 덮는 덮개부를 구비하는 제1챔버 ; 및상기 덮개부의 중앙에 형성된 가이드홀을 통하여 상기 하부몸통부의 바닥면에 소정간격 이격된 위치까지 삽입되는 중앙관으로서, 상기 중앙관의 상부를 통해 조직이 상기 제1챔버로 투입되고, 상기 제1챔버로부터 상기 액체에 부유된 상태의 세포가 배출되는 상기 중앙관을 구비하며,상기 제1챔버의 상기 중간몸통부의 내벽면에 채취된 조직의 교반을 원활하게 하기 위하여 제1날개부가 적어도 하나 이상 상기 중앙관 방향으로 형성되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 3 항에 있어서, 상기 제1챔버는,상기 중앙관을 둘러싸며 상기 가이드홀에 삽입되고, 상기 중앙관과 일체로 형성되며 상기 제1챔버를 음압상태로 만들기 위한 음압관이 형성되고,상기 가이드홀을 형성하는 벽면과 상기 음압관 사이에는 상기 제1챔버가 상기 중앙관 및 음압관과 독립적으로 회전하면서도 밀폐성을 유지하도록 리테너(retainer)가 장착되는 것을 특징으로 재생성 세포 추출 시스템.
- 제 3항에 있어서, 상기 중앙관의 하부 끝단이 상기 하부몸통부의 바닥면으로부터 이격된 위치는 바닥면에서 0.1mm ~ 3mm 사이인 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 3항에 있어서, 상기 중앙관은,상기 제1챔버의 내부에 삽입된 부분에 외측으로 돌출되는 적어도 하나이상의 보조날개가 형성되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제3항에 있어서,상기 가이드홀을 형성하는 벽면과 상기 음압관 사이에는 상기 리테너(retainer)와 함께, 상기 제1챔버의 회전을 원활하게 하는 베어링이 더 장착되며,상기 중앙관을 통하여 투입되는 조직에 존재하는 이물질을 거를수 있는 필터가 상기 중앙관 하부의 상기 하부몸통부 내측에 장착되는 것을 특징으로 하는 재생성 세포추출 시스템.
- 제 1항에 있어서, 상기 제2유닛은,일정한 직경을 가지고 수직하방으로 연장되는 입구부와, 상기 입구부 하단에서 하부로 갈수록 내경이 커지다가 최대내경을 가지는 세포분리부에서 다시 하부로갈수록 내경이 작아지는 원통형상의 상부몸체부와, 상기 상부몸체부의 하부에 일체로 형성되며 일정한 내경을 가지고 하방으로 연장되는 하부몸체부로 구성되는 제2챔버 ;상기 입구부 하단에서 하부로 갈수록 내경이 커지는 부분에서 상기 세포분리부까지를 상판부라고 할때, 상기 상판부의 내측면에 대응되도록 설치되고, 상기 제2챔버 내부에 존재하는 재생성세포 이외의 생리적 완충액이 배출되는 통로를 상기 상판부와의 사이에 형성하며, 상기 입구부의 내측으로 형성되는 제1내경을 가지는 원통형상의 제1내부입구부와 상기 제1내부입구부를 둘러싸며 제1내경보다 큰 제2내경을 가지는 제2내부입구부를 구비하는 하판부 ;상기 제1유닛으로부터 배출되는 상기 액체에 부유된 상태의 세포를 상기 제2챔버 내부로 투입시키기 위하여 상기 제1내부입구부를 통하여 상기 제2챔버내부로 삽입되는 투입관 ;상기 투입관 내측을 관통하여 상기 투입관보다 더 길게 상기 제2챔버 내부로 삽입되며, 상기 제2챔버의 상기 하부몸체부의 바닥면에 형성된 상기 재생성세포를 배출시키는 통로가되는 제1배출관 ; 및상기 제2내부입구부의 외벽면과 상기 입구부의 내벽면 사이에 삽입되어 상기 상판부와 상기 하판부 사이의 통로를 통해 배출되는 상기 재생성세포 이외의 생리적 완충액을 외부로 배출시키는 제2배출관을 구비하고,상기 제2챔버는 리테너(retainer)에 의해 상기 투입관, 상기 제1배출관 및 상기 제2배출관과 독립적으로 회전하면서도 밀폐성을 유지하는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서,상기 투입관은 외측에 상기 제1내부입구부의 외벽면을 둘러싸는 제1지지날개를 구비하고, 상기 제2배출관은 상기 입구부를 둘러싸는 제2지지날개를 구비하며,상기 제1지지날개와 상기 제2내부입구부의 내벽면 사이와, 상기 입구부의 외벽면과 상기 제2지지날개 사이에, 상기 제2챔버가 독립적으로 회전하면서도 밀폐성을 유지하기 위한 상기 리테너가 장착되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 9항에 있어서,상기 제1지지날개와 상기 제2내부입구부의 내벽면 사이와, 상기 입구부의 외벽면과 상기 제2지지날개 사이에는, 상기 리테너와 함께 상기 제2챔버의 회전을 원활하게 하는 베어링이 더 장착되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서, 상기 투입관은,상기 상부몸체부 하단까지 삽입되고, 상기 제1배출관은 상기 하부몸체부의 바닥면으로부터 0.1mm ~ 2mm 높이까지 삽입되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서, 상기 제2챔버는,상기 세포분리부에서 상기 상부몸체부의 하단까지의 내벽면에 상기 제2챔버가 회전시 교반을 원활하게 하는 제2날개부가 적어도 하나 이상 상기 투입관 방향으로 형성되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서, 상기 하판부는,상기 제1내부입구부 및 상기 제2내부입구부와,상기 제1내부입구부 및 상기 제2내부입구부의 하단에 일체로 형성되어 상기 상판부의 기울기와 동일한 기울기를 가지고 삿갓 형상으로 펼쳐지며 상기 상판부와 함께 상기 통로를 형성하는 원형판을 구비하고,상기 상판부와 상기 하판부 사이의 통로는 적어도 하나 이상 존재하고, 상기 통로와 통로 사이의 원형판 부분은 상기 상판부에 접착되는 구조인 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 13항에 있어서,상기 제2챔버의 회전속도와 상기 원형판의 길이를 조절함으로써, 상기 제2챔버의 원심력에 의해서 내부에 형성되는 혈액성분층에 따른 성분혈액 채취가 가능하며, 재생성세포 이외의 생리적 완충액이 상기 제2챔버 내부에 남는 량을 조절하는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서, 상기 하판부는,상기 제1내부입구부 및 상기 제2내부입구부와,상기 제1내부입구부 및 상기 제2내부입구부의 하단에 일체로 형성되어 상기 상판부의 기울기와 동일한 기울기를 가지고 삿갓 형상으로 펼쳐지며 상기 상판부와 함께 상기 통로를 형성하는 원형판 ; 및상기 하판부의 상기 제2내부입구부 외측을 둘러싸며, 상기 통로들 중에서 적어도 하나 이상의 통로를 선택적으로 상기 제2배출관으로 연결시키는 중공의 납작한 원판형상의 선택배출부를 구비하고,상기 상판부와 상기 하판부 사이의 통로는 적어도 하나 이상 존재하고, 상기 통로와 통로 사이의 원형판 부분은 상기 상판부에 접착되며,상기 원형판을 지름방향으로 분리할 때, 분리된 각각의 절반부분의 무게가 서로 동일하고, 하나의 절반부분에 형성되는 통로들의 길이가 서로 다르며, 분리된 각각의 절반부분에 형성되는 서로 마주보는 통로들은 동일한 길이를 가지며,상기 선택배출부의 상면에는,중앙에 상기 제2내부입구부가 관통하는 관통홀과 상기 관통홀 양측으로 상기 제2배출관과 연결되는 상면배출공이 형성되며,측면에는 상기 선택된 통로와 연결되는 측면배출공이 형성되고, 상기 측면의 하단부는 상기 원형판의 상면에 형성된 결합홈에 결합되며,상기 선택배출부는 상기 결합홈에 밀착결합된 후 회전함에 의해서 상기 통로를 선택하는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서,상기 투입관을 통하여 투입되는 상기 액상의 세포중에서 분해되지 않은 조직 또는 콜라겐덩어리를 거를수 있는 거름망이 상기 투입관 하부의 상기 하부몸체부 내측에 더 설치되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서, 상기 하판부는,상기 제1내부입구부 및 상기 제2내부입구부와,상기 제1내부입구부 및 상기 제2내부입구부의 하단에 일체로 형성되어 상기 상판부의 기울기와 동일한 기울기를 가지고 삿갓 형상으로 펼쳐지는 원형판과 상기 원형판의 끝단에 일체로 형성되며 상기 통로가 내측에 형성되는 복수개의 원통날개들을 구비하는 원형판부 ; 및상기 하판부의 상기 제2내부입구부 외측을 둘러싸며, 상기 원통날개들 중에서 적어도 하나 이상의 원통날개를 선택하고 선택된 원통날개 내측의 통로를 상기 제2배출관으로 연결시키는 중공의 납작한 원판형상의 선택배출부를 구비하고,상기 원통날개들의 상면은 상기 상판부에 접착되고, 그 길이가 서로 상이하여, 상기 제2챔버의 원심력에 의해서 내부에 형성되는 혈액성분층을 구분하여 성분혈액을 채취할 수 있으며,상기 선택배출부의 상면에는,중앙에 상기 제2내부입구부가 관통하는 관통홀과 상기 관통홀 양측으로 상기 제2배출관과 연결되는 상면배출공이 형성되며,측면에는 상기 선택된 통로와 연결되는 측면배출공이 형성되고, 상기 측면의 하단부는 상기 원형판의 상면에 형성된 결합홈에 결합되며,상기 선택배출부는 상기 결합홈에 밀착결합된 후 회전함에 의해서 상기 원통날개를 선택하는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 8항에 있어서, 상기 하판부는,상기 제1내부입구부 및 상기 제2내부입구부와,상기 제1내부입구부 및 상기 제2내부입구부의 하단에 일체로 형성되어 상기 상판부의 기울기와 동일한 기울기를 가지고 삿갓 형상으로 펼쳐지는 원형판과 상기 원형판의 끝단 및 상기 제2챔버의 내벽면에 일측단이 결합되며 상기 통로가 내측에 형성되고 타측단에 무게추가 장착되는 복수개의 원통날개들을 구비하는 원형판부를 구비하고,상기 원통날개들은 탄성이 있는 재질로 이루어지고, 상기 각각의 원통날개에 장착되는 무게추는 상기 원통날개의 밸런스를 맞추기 위하여 각각 다른 무게를 가지거나 동일한 무게를 가지며, 상기 제2챔버의 회전에 따른 원심력에 따라 상기 원통날개들이 상기 제2챔버의 내벽면 방향으로 펼쳐지며 혈액성분층에 따른 성분혈액 채취가 가능한 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 18항에 있어서,상기 원형판부는, 2개의 대칭되는 원통날개들을 구비하고, 상기 원통날개에 장착되는 상기 무게추는 동일한 무게를 가지는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 1항에 있어서, 상기 이송부는,상기 복수개의 백들과 연결되는 제1멀티웨이 밸브와 상기 제1멀티웨이밸브와, 상기 제1유닛 및 상기 제2유닛과 연결되는 제2멀티웨이밸브 및 상기 제1멀티웨이밸브와 상기 제2멀티웨이밸브를 연결하는 펌프를 구비하는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 1항에 있어서, 상기 이송부는,상기 제1및 제2멀티웨이밸브 대신 상기 복수개의 백들과 각각 연결되는 복수개의 솔레노이드밸브들을 구비하고,상기 솔레노이드밸브들에 의해 제어되는 이송관이 상기 펌프와 연결되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제1항에 있어서, 상기 이송부는,상기 제1유닛에서 상기 제2유닛으로 이송되는 상기 액상의 세포에 포함되는 분해되지 않은 효소덩어리나 콜라겐 덩어리 등의 이물질을 거를수 있는 이송필터가 삽입되는 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제22항에 있어서, 상기 이송필터는 2중필터인 것을 특징으로 하는 재생성 세포 추출 시스템.
- 제 1항에 있어서, 상기 제1유닛과 상기 제2유닛이 각각 장착되어 일정한 온도에서 회전되는 지그들을 구비하며,상기 지그들은 장착된 제1유닛과 제2유닛의 온도 및 회전속도의 조절이 가능한 것을 특징으로 하는 재생성 세포 추출 시스템.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2010800538086A CN102869761A (zh) | 2009-10-27 | 2010-10-25 | 再生细胞提取系统 |
JP2012536661A JP5826183B2 (ja) | 2009-10-27 | 2010-10-25 | 再生細胞抽出システム |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020090102082A KR101679671B1 (ko) | 2009-10-27 | 2009-10-27 | 재생성 세포 추출 시스템 |
KR10-2009-0102082 | 2009-10-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011052946A2 true WO2011052946A2 (ko) | 2011-05-05 |
WO2011052946A3 WO2011052946A3 (ko) | 2011-11-03 |
Family
ID=43922788
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/007339 WO2011052946A2 (ko) | 2009-10-27 | 2010-10-25 | 재생성 세포 추출 시스템 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP5826183B2 (ko) |
KR (1) | KR101679671B1 (ko) |
CN (1) | CN102869761A (ko) |
WO (1) | WO2011052946A2 (ko) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014039697A1 (en) * | 2012-09-06 | 2014-03-13 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
WO2015035221A1 (en) * | 2013-09-05 | 2015-03-12 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US9206387B2 (en) | 2010-07-09 | 2015-12-08 | The Gid Group, Inc. | Method and apparatus for processing adipose tissue |
US9260697B2 (en) | 2010-07-09 | 2016-02-16 | The Gid Group, Inc. | Apparatus and methods relating to collecting and processing human biological material containing adipose |
US9296984B2 (en) | 2010-07-09 | 2016-03-29 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US9909095B2 (en) | 2010-07-09 | 2018-03-06 | The Gid Group, Inc. | Tissue processing apparatus with filter pierceable to remove product and method for processing adipose tissue |
US10092711B2 (en) | 2014-05-02 | 2018-10-09 | Lifecell Corporation | Injection sensor with feedback mechanism |
US10286122B2 (en) | 2015-10-21 | 2019-05-14 | Lifecell Corporation | Systems and methods for tube management |
US10314955B2 (en) | 2015-10-21 | 2019-06-11 | Lifecell Corporation | Systems and methods for medical device control |
USD851777S1 (en) | 2017-01-30 | 2019-06-18 | Lifecell Corporation | Canister-type device for tissue processing |
EP3466542A4 (en) * | 2016-06-07 | 2019-11-06 | CG Bio Co., Ltd. | CENTRIFUGE TANK AND METHOD FOR ISOLATION OF SVF USING THE SAME |
US10472603B2 (en) | 2016-08-30 | 2019-11-12 | Lifecell Corporation | Systems and methods for medical device control |
US10729827B2 (en) | 2015-12-22 | 2020-08-04 | Lifecell Corporation | Syringe filling device for fat transfer |
US11732233B2 (en) | 2017-07-18 | 2023-08-22 | Gid Bio, Inc. | Adipose tissue digestion system and tissue processing method |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101357160B1 (ko) * | 2011-12-14 | 2014-02-17 | 주식회사 휴림바이오셀 | 재생성 세포 추출 시스템 및 이를 이용한 재생성 세포 추출 방법 |
KR101316575B1 (ko) * | 2011-12-14 | 2013-10-15 | 도병록 | 페리스테틱 펌프 및 이를 이용한 재생성 세포 추출 시스템 |
KR101466923B1 (ko) * | 2013-01-17 | 2014-12-04 | 주식회사 휴림바이오셀 | 재생성 세포 추출장치, 재생성 세포 추출 시스템, 이를 이용한 재생성 세포 추출방법 |
CA2903943A1 (en) * | 2013-03-04 | 2014-09-12 | Swiss Stem Cell Foundation | A system for extraction of cells from a sample of tissue |
KR101313048B1 (ko) * | 2013-04-09 | 2013-09-30 | 김준우 | 성분 분리기 |
KR101343577B1 (ko) * | 2013-05-03 | 2013-12-20 | 김준우 | 성분 분리기 |
CN103604679B (zh) * | 2013-11-25 | 2015-12-30 | 武汉友芝友医疗科技有限公司 | 一种循环肿瘤细胞捕获仪及其捕获染色方法 |
WO2016006850A1 (ko) * | 2014-07-08 | 2016-01-14 | 주식회사 시지바이오 | 세포분리 용기, 세포분리 시스템 및 세포분리 방법 |
KR101667848B1 (ko) * | 2014-07-08 | 2016-10-19 | (주)시지바이오 | 세포분리 용기 및 이를 이용한 세포분리 방법 |
KR101707474B1 (ko) * | 2015-03-13 | 2017-02-17 | 주식회사 디더블유메디팜 | 통합밸브유닛과 이를 이용한 유핵세포추출장치 |
CN107118944A (zh) * | 2017-06-19 | 2017-09-01 | 方育峰 | 一种提高自体脂肪隆胸术中脂肪细胞生存率的装置 |
CN107475098B (zh) * | 2017-08-15 | 2023-08-15 | 中国人民解放军第二军医大学第二附属医院 | 一种无菌条件下髌下脂肪垫快速匀浆分装装置及方法 |
KR20210108048A (ko) * | 2020-02-25 | 2021-09-02 | (주)시지바이오 | 원심 분리 용기 |
CN114315993B (zh) * | 2021-12-27 | 2022-09-02 | 江苏艾洛特医药研究院有限公司 | 一种细菌鞭毛提纯装置 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09276396A (ja) * | 1996-04-03 | 1997-10-28 | Haemonetics Corp | 血液処理用遠心分離器ボウル |
JP2001017540A (ja) * | 1999-06-03 | 2001-01-23 | Haemonetics Corp | 血液処理遠心分離ボウルおよび全血から血漿分画を収集する方法 |
JP2006020756A (ja) * | 2004-07-07 | 2006-01-26 | Terumo Corp | 遠心分離器および血液成分採取回路 |
JP2007236665A (ja) * | 2006-03-09 | 2007-09-20 | Asahi Kasei Corp | 血液成分分離装置及びその使用方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3202145A1 (de) * | 1982-01-23 | 1983-08-11 | A. u. K. Müller GmbH & Co KG, 4000 Düsseldorf | Mehrwegeventil, insbesondere zur verwendung in dialyse-geraeten |
JPH05310781A (ja) * | 1992-05-13 | 1993-11-22 | Mitsui Toatsu Chem Inc | L−α−アスパルチル−L−フェニルアラニンメチルエステルの改良された結晶製造法 |
JP3339130B2 (ja) * | 1993-09-28 | 2002-10-28 | 東北電力株式会社 | 化学洗浄方法 |
JPH07231776A (ja) * | 1994-02-24 | 1995-09-05 | Kirin Eng Kk | 発酵糖の製造装置 |
AU693233B2 (en) * | 1994-07-29 | 1998-06-25 | Gambro Lundia Ab | Method and device for measuring the concentration of a substance in a solution |
US6629919B2 (en) * | 1999-06-03 | 2003-10-07 | Haemonetics Corporation | Core for blood processing apparatus |
JP2007524396A (ja) * | 2003-06-25 | 2007-08-30 | サイトリ セラピューティクス インコーポレイテッド | 組織から再生細胞を分離して濃縮するためのシステム及び方法 |
CA2609361C (en) * | 2005-05-25 | 2017-11-14 | Cytori Therapeutics, Inc. | Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions |
JP2007282552A (ja) * | 2006-04-14 | 2007-11-01 | Biomaster Inc | 細胞分離方法および細胞分離システム |
US20080113357A1 (en) * | 2006-06-29 | 2008-05-15 | Millipore Corporation | Filter device for the isolation of a nucleic acid |
JP2008131881A (ja) * | 2006-11-28 | 2008-06-12 | Kirin Brewery Co Ltd | 酵母の脱苦味処理装置及び脱苦味処理方法 |
JP5078020B2 (ja) | 2008-02-13 | 2012-11-21 | オリンパス株式会社 | 遠心分離容器 |
-
2009
- 2009-10-27 KR KR1020090102082A patent/KR101679671B1/ko active IP Right Grant
-
2010
- 2010-10-25 WO PCT/KR2010/007339 patent/WO2011052946A2/ko active Application Filing
- 2010-10-25 CN CN2010800538086A patent/CN102869761A/zh active Pending
- 2010-10-25 JP JP2012536661A patent/JP5826183B2/ja not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH09276396A (ja) * | 1996-04-03 | 1997-10-28 | Haemonetics Corp | 血液処理用遠心分離器ボウル |
JP2001017540A (ja) * | 1999-06-03 | 2001-01-23 | Haemonetics Corp | 血液処理遠心分離ボウルおよび全血から血漿分画を収集する方法 |
JP2006020756A (ja) * | 2004-07-07 | 2006-01-26 | Terumo Corp | 遠心分離器および血液成分採取回路 |
JP2007236665A (ja) * | 2006-03-09 | 2007-09-20 | Asahi Kasei Corp | 血液成分分離装置及びその使用方法 |
Cited By (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9909095B2 (en) | 2010-07-09 | 2018-03-06 | The Gid Group, Inc. | Tissue processing apparatus with filter pierceable to remove product and method for processing adipose tissue |
US11666605B2 (en) | 2010-07-09 | 2023-06-06 | Gid Bio, Inc. | Method for preparing a product comprising stromal vascular fraction cells |
US9206387B2 (en) | 2010-07-09 | 2015-12-08 | The Gid Group, Inc. | Method and apparatus for processing adipose tissue |
US9260697B2 (en) | 2010-07-09 | 2016-02-16 | The Gid Group, Inc. | Apparatus and methods relating to collecting and processing human biological material containing adipose |
US9296984B2 (en) | 2010-07-09 | 2016-03-29 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US9909094B2 (en) | 2010-07-09 | 2018-03-06 | The Gid Group, Inc. | Tissue processing apparatus with mixing device and method for processing adipose tissue |
US9950015B2 (en) | 2010-07-09 | 2018-04-24 | The Gid Group, Inc. | Tissue processing apparatus with fluid suction features and methods relating to collecting and processing human biological material |
US10138457B2 (en) | 2010-07-09 | 2018-11-27 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US10898524B2 (en) | 2010-07-09 | 2021-01-26 | Gid Bio, Inc. | Portable apparatus with mixing device and methods relating to collecting and processing human biological material comprising adipose |
EP3075841A1 (en) * | 2012-09-06 | 2016-10-05 | The GID Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
WO2014039697A1 (en) * | 2012-09-06 | 2014-03-13 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US11261418B2 (en) | 2012-09-06 | 2022-03-01 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
EP3896145A1 (en) * | 2012-09-06 | 2021-10-20 | GID BIO, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US10336980B2 (en) | 2013-09-05 | 2019-07-02 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US11898138B2 (en) | 2013-09-05 | 2024-02-13 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
WO2015035221A1 (en) * | 2013-09-05 | 2015-03-12 | The Gid Group, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US11649427B2 (en) | 2013-09-05 | 2023-05-16 | Gid Bio, Inc. | Tissue processing apparatus and method for processing adipose tissue |
US10092711B2 (en) | 2014-05-02 | 2018-10-09 | Lifecell Corporation | Injection sensor with feedback mechanism |
US10940273B2 (en) | 2014-05-02 | 2021-03-09 | Lifecell Corporation | Injection sensor with feedback mechanism |
US10286122B2 (en) | 2015-10-21 | 2019-05-14 | Lifecell Corporation | Systems and methods for tube management |
US10314955B2 (en) | 2015-10-21 | 2019-06-11 | Lifecell Corporation | Systems and methods for medical device control |
US10729827B2 (en) | 2015-12-22 | 2020-08-04 | Lifecell Corporation | Syringe filling device for fat transfer |
EP3466542A4 (en) * | 2016-06-07 | 2019-11-06 | CG Bio Co., Ltd. | CENTRIFUGE TANK AND METHOD FOR ISOLATION OF SVF USING THE SAME |
US11091733B2 (en) | 2016-08-30 | 2021-08-17 | Lifecell Corporation | Systems and methods for medical device control |
US10472603B2 (en) | 2016-08-30 | 2019-11-12 | Lifecell Corporation | Systems and methods for medical device control |
US11717602B2 (en) | 2016-08-30 | 2023-08-08 | Lifecell Corporation | Systems and methods for medical device control |
USD921216S1 (en) | 2017-01-30 | 2021-06-01 | Lifecell Corporation | Canister-type device for tissue processing |
USD851777S1 (en) | 2017-01-30 | 2019-06-18 | Lifecell Corporation | Canister-type device for tissue processing |
USD889680S1 (en) | 2017-01-30 | 2020-07-07 | Lifecell Corporation | Canister-type device for tissue processing |
US11732233B2 (en) | 2017-07-18 | 2023-08-22 | Gid Bio, Inc. | Adipose tissue digestion system and tissue processing method |
Also Published As
Publication number | Publication date |
---|---|
CN102869761A (zh) | 2013-01-09 |
KR20110045479A (ko) | 2011-05-04 |
WO2011052946A3 (ko) | 2011-11-03 |
JP5826183B2 (ja) | 2015-12-02 |
JP2013507983A (ja) | 2013-03-07 |
KR101679671B1 (ko) | 2016-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011052946A2 (ko) | 재생성 세포 추출 시스템 | |
EP1266959B1 (en) | Devices and method for cell harvesting | |
WO2020085688A1 (ko) | 지방줄기세포 분리장치 | |
US7514075B2 (en) | Systems and methods for separating and concentrating adipose derived stem cells from tissue | |
EP2380970B1 (en) | Systems and methods for separating and concentrating regenerative cells from tissue | |
US5837444A (en) | Islet cell transplantation machine for diabetes cure | |
WO2013133529A1 (ko) | 성분 분리기 | |
WO2009149691A2 (de) | Verfahren und vorrichtung zum trennen von gewebezellen aus einer flüssigkeit | |
CN109280635B (zh) | 一种子宫内膜干细胞分离方法 | |
WO2011062313A1 (ko) | 줄기세포 분리방법 | |
KR20180073688A (ko) | 인간 및 동물 조직으로부터 세포 분획을 단리하기 위한 장치 및 그 사용 방법 | |
WO2024101886A1 (ko) | 용액 농축용 키트 | |
CN111909896B (zh) | 一种脂肪组织干细胞的提取方法 | |
WO2016006850A1 (ko) | 세포분리 용기, 세포분리 시스템 및 세포분리 방법 | |
WO2014168311A1 (ko) | 성분 분리기 | |
KR20160045050A (ko) | 재생성 세포 추출 시스템 | |
WO2017051969A1 (ko) | 지방조직 유래 기질혈관분획 분리용 키트 및 이를 이용한 지방조직 유래 기질혈관분획의 분리 방법 | |
WO2021256769A1 (ko) | 세포배양기 | |
KR101013927B1 (ko) | 줄기세포 분리방법 | |
KR20150051026A (ko) | 대용량 지방유래 줄기세포 분리용 튜브 및 이를 이용한 분리방법 | |
CN220941231U (zh) | 一种牛血浆高效脱纤分离装置 | |
WO2014178570A1 (ko) | 성분 분리기 | |
CN205635588U (zh) | 一种快速分离牙髓干细胞的试剂盒 | |
CN208599958U (zh) | 一种自动排水的医用离心机 | |
WO2024071735A1 (ko) | 혈청안약 제조 키트 및 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080053808.6 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10827030 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012536661 Country of ref document: JP |
|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1201001946 Country of ref document: TH |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 10827030 Country of ref document: EP Kind code of ref document: A2 |